[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2006, 32(6) 368-370 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
ݡ����
��������
�����Ʒ�
���������������
������
���
PubMed
Article by QIN Xiao-lei
Article by XU Jin-hua

����������ݡ����

������, ���

������ѧ������ɽҽԺ, �Ϻ�200040

ժҪ��

����������ݡ�����������ط���ݡ������������͡�����֢״��������,�Ҿ����Ŵ�����������������ݡ����ķ��������в���ȷ,��������������Ը��׺���IgE�����IgE������������й�,ͬʱ�ж������߷��ӡ�����ϸ���������С�����Ѫ��Ƥ��������ɸѡ����������ݡ�������Ҫ���������ڽ����������ƿɻ�ýϺõ���Ч��

�ؼ����� ݡ����   ��������   �����Ʒ�  

Autoimmune urticaria

Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200042, China

Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200042, China

Abstract:

Autoimmune urticaria is a special subset of chronic idiopathic urticaria (CIU). The patients often present with severe symptoms and have a genetic background. The pathogenesis of the disease is still unclear. The autoantibodies against the high affinity IgE receptor or IgE may play an important role. Immune cells and molecules also take part in the pathogenesis. Autologous serum skin test is the main method to screen autoimmune urticaria. Immunotherapy is effective for this disease.

Keywords: Urticaria   Autoimmunity   Immunotherapy  
�ո����� 2006-02-20 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Tong LJ,Balakrishnan G,Kochan JP,et al.Assessment of autoimmunity in patients with chronic urticaria.J Allergy Clin Immunol,1997,99:461-465.
[2] Fiebiger E,Hammerschmid F,Stingl G,et al.Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders.Identification of a structure-fimction relationship.J Clin Invest,1998,101:243-251.
[3] Greaves M.Autoimmune urticaria.Clin Rev Allergy Immunol,2002,23:171-183.
[4] Soundararajan S,Kikuchi Y,Joseph K,et al.Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria.J Allergy Clin Immunol,2005,115:815-821.
[5] Grattan CE,Boon AP,Eady RA,et al.The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions.Iht Arch Allergy Appl Immunol,1990,93:198-204.
[6] Caproni M,Volpi W,Macchia D,et al.Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test.Exp Dermatol,2003,12:621-628.
[7] Caproni M,Giomi B,Volpi W,et al.Chronic idiopathic urticaria:infiltrating cells and related cytokines in autologous serum-induced wheals.Clin Immunol,2005,114:284-292.
[8] Ferrer M,Luquin E,Sanchez-Ibarrola A,et al.Secretion of cytokines,histamine and leukotrienes in chronic urticaria.Int Arch Allergy Immunol,2002,129:254-260.
[9] Hidvegi B,Nagy E,Szabo T,et al.Correlation between T-cell and mast cell activity in patients with chronic urticaria.Int Arch Allergy Immunol,2003,132:177-182.
[10] Piconi S,Trabattoni D,Iemoli E,et al.Immune profiles of patients with chronic idiopathic urticaria.Int Arch Allergy Immunol,2002,128:59-66.
[11] Garmendia JV,Zabaleta M,Blanca I,et al.Total and biologically active serum-soluble CD154 in patients with chronic idiopathic urticaria.Allergy Asthma Proc,2004,25:121-125.
[12] O' Donnell BF,O'Neill CM,Francis DM,et al.Human leucocyte antigen class �� associations in chronic idiopathic urticaria.Br J Dermatol,1999,140:853-858.
[13] Confino-Cohen R,Aharoni D,Goldberg A,et al.Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria.J Allergy Clin Immunol,2002,109:349-356.
[14] Asero R.Chronic idiopathic urticaria:a family study.Ann Allergy Asthma Immunol,2002,89:195-196.
[15] Toubi E,Kessel A,Avshovich N,et al.Clinical and laboratory parameters in predicting chronic urticaria duration:a prospective study of 139 patients.Allergy,2004,59:869-873.
[16] Sabroe RA,Grattan CE,Francis DM,et al.The autologous serum skin test:a screening test for autoantibodies in chronic idiopathic urticaria.Br J Dermatol,1999,140:446-452.
[17] Asero R,Lorini M,Chong SU,et al.Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells.Clin Exp Allergy,2004,34:1111-1114.
[18] Grattan CE,Francis DM,Slater NG,et al.Plasmapheresis for severe,unremitting,chronic urticaria.Lancet,1992,339:1078-1080.
[19] Grattan C,Powell S,Humphreys F.Management and diagnostic guidelines for urticaria and angio-oedema.Br J Dermatol,2001,144:708-714.
[20] Grattan CE,O'Donnell BF,Francis DM,et al.Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.Br J Dermatol,2000,143:365-372.
[21] O'Donnell BF,Barr RM,Black AK,et al.Intravenous immunoglobulin in autoimmune chronic urticaria.Br J Dermatol,1998,138:101-106.
[22] Sabroe RA,Greaves MW.The pathogenesis of chronic idiopathic urticaria.Arch Dermatol,1997,133:1003-1008.
[23] Reeves GE,Boyle MJ,Bonfield J,et al.Impact of hydroxychloroquine therapy on chronic urticaria:chronic autoimmune urticaria study and evaluation.Intern Med J,2004,34:182-186.
[24] Bagenstose SE,Levin L,Bemstein JA.The addition ofzafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.J Allergy Clin Immunol,2004,113:134-140.
�������������
1���Ų�Ƽ,���̸�.������Ѫ����ϸ����������ͻ״ϸ�����ۿ��鰷ҩ��������ݡ�������Ч[J]. ����Ƥ���Բ�ѧ��־, 2006,32(3): 176-
2������,�ƻ�,���.��ͯ���и��Ͳ����ڸ�Ů����ݡ��������ƹ۵�[J]. ����Ƥ���Բ�ѧ��־, 2008,34(5): 290-292
3�������,����,������,��·��,�����,���̻�,��ҵ��,������,.Ѫ��IL-15��IL-21��IgEˮƽ��ݡ����Ĺ�ϵ[J]. ����Ƥ���Բ�ѧ��־, 2009,35(1): 3-5
4��������,���,�˾�.Cryopyrin��������������ۺ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2009,35(2): 68-70
5�����r ������ ��Ԩ��.ʳ�ﲻ�����ڳ�����̬��Ӧ��Ƥ���������еļ��[J]. ����Ƥ���Բ�ѧ��־, 2009,35(5): 289-290
6�����̻� ������ �����.��CD20�������о���չ�����ٴ�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2011,37(2): 80-83
7����ӱ ��ѧ��.ְҵ�ԽӴ���ݡ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2011,37(5): 294-297
8����־�� Ҧ��.����ϩ�����׿�����³˾����Ƥ���Ƶ�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2012,38(3): 150-152
9�������� ���.����������ݡ����[J]. ����Ƥ���Բ�ѧ��־, 2006,32(6): 368-368
10��������, ��¡��, �Խ���, ��ǧ��.�����ط���ݡ�����ҩ�����ƽ�չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 274-276
11�������ֱ���, ���л���У.�����ط���ݡ����ķ�������[J]. ����Ƥ���Բ�ѧ��־, 1998,24(4): 235-237
12������ɽ����, ��������У.��������������ݡ����[J]. ����Ƥ���Բ�ѧ��־, 2000,26(3): 135-138
13����ѧ������, ��������У.ݡ������Ѫ����[J]. ����Ƥ���Բ�ѧ��־, 2000,26(4): 203-205
14�������ֱ���, �������У.����˹͡������ݡ�����о���˫�ػ���[J]. ����Ƥ���Բ�ѧ��־, 2001,27(3): 176-178
15���º������, ��־����У.ݡ������Ѫ����[J]. ����Ƥ���Բ�ѧ��־, 2001,27(4): 238-240
16��������, ��ѧ��, ��ɭ.����������ݡ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2003,29(5): 299-302
17��������, ��¡��, �Խ���, ��ǧ��.�����ط���ݡ�����ҩ�����ƽ�չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 274-276
18���Ų�Ƽ, ���̸�.������Ѫ����ϸ����������ͻ״ϸ�����ۿ��鰷ҩ��������ݡ�����ҩЧ[J]. ����Ƥ���Բ�ѧ��־, 2006,32(3): 176-178
19���ƻ�, ���, ֣־��.CC����������������ݡ����[J]. ����Ƥ���Բ�ѧ��־, 2006,32(5): 303-305
20������, ���.�����ݸ˾�������ݡ����ķ�������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(5): 284-286
21��������, ��¡��, �Խ���, ��ǧ��.�����ط���ݡ�����ҩ�����ƽ�չ[J]. ����Ƥ���Բ�ѧ��־, 2005,31(5): 274-276
22������Ƽ ��� ������ ����ΰ ������ ������ ����� �߶�.�ʴ�ϸ���ͷ��鰷���Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2013,39(5): 309-311
23����� ���� �º� �ܺ��� ������.ɫ����ݡ����һ��[J]. ����Ƥ���Բ�ѧ��־, 2014,40(1): 64-64
24�������� ������.��������������ݡ�����о���չ[J]. ����Ƥ���Բ�ѧ��־, 2016,42(4): 233-235
25����ΰ�� ��� �ڲ�.������Ӧ�����е�DNA�׻�������Ŵ�ѧ���ػ���[J]. ����Ƥ���Բ�ѧ��־, 2016,42(4): 254-256

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־